Pramod Gupta, PhD

Pramod Gupta, PhD

CEO, Director

Dr. Gupta is a pharmaceutical executive with 30 years’ experience at large as well as small companies.  He has extensive experience in…

View Full Bio
Mamta Swaroop, MD, FACS, FICS

Mamta Swaroop, MD, FACS, FICS

Interim CMO, Director

Dr. Swaroop is an Associate Professor of Surgery in the Division of Trauma and Critical Care Surgery and is on the faculty of the Center for…

View Full Bio
Scott VanderMeer, M.B.A.

Scott VanderMeer, M.B.A.

Co-founder, Interim CFO, Director

Mr. VanderMeer is a co-founder and a Managing Partner of Infusion 51a LP, International Infusion Holdings LLC, and International Infusion…

View Full Bio
Tina K. Runk, M.B.A.

Tina K. Runk, M.B.A.

Co-founder, Director, VP, Pre-clinical and Clinical Operations

Ms. Runk has more than 35 years of experience in research, including all phases of pre-clinical and clinical drug development. Her research…

View Full Bio
Steven M. Rubinfeld, MSW

Steven M. Rubinfeld, MSW

Co-founder, VP Clinical Development

Mr. Rubinfeld has more than 22 years of experience in drug development, site initiation, site management, and contract negotiations. He has spent…

View Full Bio
Elise Brownell, MS, MPhil, PhD

Elise Brownell, MS, MPhil, PhD

Interim Head, Project and Portfolio Planning and Management

Dr. Brownell has spent the last 35 years in the bio/pharmaceutical arena where she has played key roles in Discovery, Development and…

View Full Bio
Peter K. Seperack, PhD, JD

Peter K. Seperack, PhD, JD

Interim Director, Intellectual Property

Dr. Seperack has spent the last 32 years as a biopharmaceutical researcher and as a Biotech patent attorney.  As a Post-Doctoral Fellow…

View Full Bio
Sean Phillips

Sean Phillips

Director of Investor Relations

Mr. Phillips has achieved success with well-established companies such as JP Morgan Chase, Capital One and Citibank to name a few. After spending…

View Full Bio